☆ 4.7 Article

Quantitative Sensory Testing in Late-Onset ATTRv Presymptomatic Subjects: A Single Center Experience

BIOMEDICINES (2022)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: Data from an early-access program in Italy

Marco Luigetti et al.

Summary: This article presents the long-term outcomes of Italian ATTRv patients who received inotersen within an early-access program. The study found that inotersen has a favorable safety profile and that the severity of neurologic disease at baseline is the main factor associated with disease progression.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation

Luca Leonardi et al.

Summary: The study found that patients with ATTRv-PN and asymptomatic carriers show early nerve pathological and functional changes, with skin biopsy and QST providing valuable insights into disease onset and progression.

NEUROLOGICAL SCIENCES (2022)

Add to Collection

Letter Clinical Neurology

Cutaneous silent period in ATTRv carriers: a possible early marker of nerve damage?

Marco Luigetti et al.

NEUROLOGICAL SCIENCES (2022)

Add to Collection

Review Clinical Neurology

Hereditary transthyretin amyloidosis overview

Fiore Manganelli et al.

Summary: Hereditary amyloidogenic transthyretin (ATTRv) amyloidosis is a rare autosomal dominantly inherited disorder caused by mutations in the transthyretin (TTR) gene. The disease is characterized by amyloid deposits and monomer-oligomer toxicity in various systems, with the peripheral nervous system and heart being most affected. Recent advancements in understanding the pathogenesis have led to the development of novel drugs that are rapidly changing the natural history of the disease, posing challenges for timely diagnosis, presymptomatic testing, and management of carriers.

NEUROLOGICAL SCIENCES (2022)

Add to Collection

Article Clinical Neurology

Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Marcia Waddington-Cruz et al.

Summary: In the THAOS survey, late-onset ATTRv Val30Met amyloidosis is common and presents with more severe neurological and cardiac manifestations. The heterogeneity of the disease may complicate diagnosis, but increased recognition of late-onset ATTRv Val30Met amyloidosis could lead to improved patient outcomes.

NEUROLOGY AND THERAPY (2021)

Add to Collection

Article Anesthesiology

Increased peptidergic fibers as a potential cutaneous marker of pain in diabetic small fiber neuropathy

Pall Karlsson et al.

Summary: Painful diabetic polyneuropathy (DPN) patients showed increased density of dermal peptidergic fibers in the skin, which correlated with pain ratings. This finding offers new insight into the pathophysiological mechanisms of pain in diabetes and suggests potential new therapeutic targets.

PAIN (2021)

Add to Collection

Review Clinical Neurology

The neuropathy in hereditary transthyretin amyloidosis: A narrative review

Stefano Tozza et al.

Summary: Hereditary transthyretin amyloidosis (ATTRv) is an adult-onset condition caused by mutation of the TTR gene, leading to extracellular deposition of amyloid fibrils in tissues, especially in the peripheral nervous system and heart. Despite increased awareness among neurologists, misdiagnosis and delayed correct diagnosis are common. Neuropathy in ATTRv involves progressive axonal loss and demyelination, with features varying based on type and stage of the disease.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2021)

Add to Collection

Article Biochemistry & Molecular Biology

ATTRv amyloidosis Italian Registry: clinical and epidemiological data

Massimo Russo et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2020)

Add to Collection

Article Neurosciences

hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers

Marco Luigetti et al.

BRAIN SCIENCES (2020)

Add to Collection

Article Genetics & Heredity

Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus

M. Grandis et al.

ORPHANET JOURNAL OF RARE DISEASES (2020)

Add to Collection

Review Neurosciences

Contribution of Skin Biopsy in Peripheral Neuropathies

Maria Nolano et al.

BRAIN SCIENCES (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations*

Isabel Conceicao et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2019)

Add to Collection

Article Clinical Neurology

Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy

Armindo Fernandes et al.

BRAIN COMMUNICATIONS (2019)

Add to Collection

Article Clinical Neurology

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

A. Cortese et al.

JOURNAL OF NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?

D. Adams et al.

REVUE NEUROLOGIQUE (2016)

Add to Collection

Article Clinical Neurology

Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers

Jean-Pascal Lefaucheur et al.

JOURNAL OF NEUROLOGY (2013)

Add to Collection

Article Neurosciences

TRPM8 and Nav1.8 sodium channels are required for transthyretin-induced calcium influx in growth cones of small-diameter TrkA-positive sensory neurons

Robert J. Gasperini et al.

MOLECULAR NEURODEGENERATION (2011)

Add to Collection

Article Clinical Neurology

Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy

Victoria Heldestad et al.

MUSCLE & NERVE (2007)

Add to Collection

Article Biochemistry & Molecular Biology

Binding of amyloidogenic transthyretin to the plasma membrane alters membrane fluidity and induces neurotoxicity

X Hou et al.

BIOCHEMISTRY (2005)

Add to Collection

Article Clinical Neurology

Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy

H Koike et al.

NEUROLOGY (2004)

Add to Collection

Article Medicine, Research & Experimental

Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers

MM Sousa et al.

LABORATORY INVESTIGATION (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.